Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Terlivaz® (terlipressin) – New orphan drug approval
September 14, 2022 - Mallinckrodt announced the FDA approval of Terlivaz (terlipressin), to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function.
